Open Source Clinical Trial Software Gets Attention at DIA Annual Meeting
Using open source clinical trial software in regulatory environments will be the topic of a panel discussion at the upcoming DIA annual meeting on June 24th in Boston Cambridge, MA (PRWEB) May 12, 2008 -- Open source clinical trial software will be the topic of a panel discussion at the upcoming DIA annual meeting on June 24th in Boston. This presentation will evaluate how open, standards-based software can alleviate the challenges of flexibility, interoperability, and cost in regulated clinical research environments. Presenters will discuss the unique advantages and challenges in developing and using open source software for tasks such as electronic data capture, and provide an overview of other open source technologies currently being used in clinical trials. As clinical research becomes more informatics intensive, organizations are looking towards transparent, standards-based systems to better meet challenges of flexibility, interoperability, compliance, and cost. As part of this, Open Source Software (OSS) is becoming a key IT component in the clinical research enterprise. OSS, defined loosely as software that allows programmers to openly read, redistribute, and modify the source code for a piece of software, can exist in several contexts. It can serve as a platform or operating system (Linux), as development tools, (compilers and IDEs such as GCC or Eclipse), as infrastructure applications (Apache web server, caGrid), or as user-facing applications (Firefox, Alfresco, OpenClinica, R). Because it is so diverse, chances are high that OSS is being used somewhere in every sizeable organization. The core objective of enterprise IT is to solve business needs at minimum risk and cost to the organization. The DIA session will be in a panel format, led by Cal Collins, CEO of Akaza Research, LLC. Other panelists will include Darin Morley, Director of Application Development at PharPoint Research; Mark Paul, CEO of Statworks, Inc., and Brian Shoemaker, Principal Consultant with ShoeBar Associates
About OpenClinica®
OpenClinica is open source web-based electronic data capture software for clinical research. It facilitates protocol configuration, design of case report forms, clinical data capture, and study/data management. OpenClinica supports HIPAA and 21 CFR Part 11 guidelines and is designed as a lightweight, standards-based, extensible, and modular platform. All versions of OpenClinica are available for download at www.OpenClinica.org. About Akaza Research®
Akaza Research, the leading provider of open source clinical trial software, is headquartered in Cambridge, Massachusetts. Supported by the National Institutes of Health (NIH), Akaza has developed and commercialized OpenClinica, the preeminent open source clinical trial data capture and management software platform. Akaza brings Open Source Software (OSS) into the mainstream of the clinical research enterprise by making robust, flexible, standards-based systems accessible for private and public research. Akaza Research provides OpenClinica support, training, and consulting services to its customers worldwide. See www.akazaresearch.com. ###
Simillar Articles
|
